2021
The relationship of smoking and unhealthy alcohol use to the HIV care continuum among people with HIV in an integrated health care system
Satre DD, Levine-Hall T, Sterling SA, Young-Wolff KC, Lam JO, Alexeeff S, Hojilla JC, Williams A, Justice AC, Sterne J, Cavassini M, Bryant KJ, Williams EC, Horberg MA, Volberding P, Weisner C, Silverberg MJ. The relationship of smoking and unhealthy alcohol use to the HIV care continuum among people with HIV in an integrated health care system. Drug And Alcohol Dependence 2021, 219: 108481. PMID: 33429295, PMCID: PMC7869693, DOI: 10.1016/j.drugalcdep.2020.108481.Peer-Reviewed Original ResearchConceptsUnhealthy alcohol useHIV care continuum outcomesIntegrated health care systemCare continuum outcomesAlcohol useHealth care systemContinuum outcomesCare continuumOdds ratioHigher oddsKaiser Permanente Northern CaliforniaCare systemHIV RNA controlPrimary care screeningHIV care continuumRelationship of smokingAdjusted odds ratioSeparate logistic regression modelsLogistic regression modelsRace/ethnicityHIV careHIV RNASmoking statusMean ageCare screening
2017
Risk of Acute Liver Injury With Antiretroviral Therapy by Viral Hepatitis Status
Gowda C, Newcomb CW, Liu Q, Carbonari DM, Lewis JD, Forde KA, Goldberg DS, Reddy KR, Roy JA, Marks AR, Schneider JL, Kostman JR, Tate JP, Lim JK, Justice AC, Goetz MB, Corley DA, Re V. Risk of Acute Liver Injury With Antiretroviral Therapy by Viral Hepatitis Status. Open Forum Infectious Diseases 2017, 4: ofx012. PMID: 28470014, PMCID: PMC5407218, DOI: 10.1093/ofid/ofx012.Peer-Reviewed Original ResearchSevere acute liver injuryAcute liver injuryViral hepatitis statusAntiretroviral therapyHepatitis statusAminotransferase elevationHazard ratioLiver aminotransferasesLiver injuryHigh riskHIV/viral hepatitisKaiser Permanente Northern CaliforniaVeterans Aging Cohort StudyNonnucleoside reverse transcriptase inhibitorAbacavir/lamivudineProtease inhibitor useTenofovir/emtricitabineAging Cohort StudyHuman immunodeficiency virusRisk of hepatotoxicityConfidence intervalsReverse transcriptase inhibitorART initiationCoinfected PatientsART regimens